BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:13 PM
 | 
Sep 10, 2012
 |  BC Extra  |  Company News

Biogen Idec sells Benlysta royalty rights

Biogen Idec Inc. (NASDAQ:BIIB) sold its long-term royalty stream for lupus drug Benlysta belimumab to investment firm DRI Capital in exchange for larger payments over a shorter period. Biogen Idec will receive regular payments from DRI during the period of October 2011...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >